Healthy Habits New Targeted Therapies for IgA Nephropathy: Key InsightsBy 8okaybaby@gmail.comFebruary 11, 20260 While sparsentan blocks both ETA and AT1 receptors, atrasentan (Vanrafia) is a targeted therapy that focuses only on ETA receptors.…
